P52:F NEWBURY PHARMACEUTICALS

EUR 0.23 -0.01 ( -3.38%)
Icon

NEWBURY PHARMACEUTICALS (P52:F) Financial Statements

COMMON STOCK | Drug Manufacturers - Specialty & Generic | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.23

-0.01 (-3.38%)

EUR 7.61M

N/A

EUR -1.00

N/A

Icon

P52:F

NEWBURY PHARMACEUTICALS (EUR)
COMMON STOCK | F
EUR 0.23
-0.01 ( -3.38%)

NEWBURY PHARMACEUTICALS (P52:F) Annual Income Statement ()

P52:F Quarterly Financials ()

Frequently Asked Questions About NEWBURY PHARMACEUTICALS (P52:F) Stock

NEWBURY PHARMACEUTICALS's (P52:F) last reported annual revenue was N/A.

NEWBURY PHARMACEUTICALS's (P52:F) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

NEWBURY PHARMACEUTICALS's(P52:F) is not profitable as of its last reported annual financials.

The net profit margin for NEWBURY PHARMACEUTICALS's(P52:F) from its laster reported year is N/A

The return on equity (ROE) for NEWBURY PHARMACEUTICALS's(P52:F) from its last reported annual financials is : -30.42%

The return on assets (ROA) for NEWBURY PHARMACEUTICALS's(P52:F) from its last reported annual financials is : -12.96%

The return on invested capital (ROIC) for NEWBURY PHARMACEUTICALS's(P52:F) from its last reported annual financials is : 0.00%

The Debt to Equity ratio for NEWBURY PHARMACEUTICALS's(P52:F) from its last reported annual financials is : 0.00%

The dividend yield for NEWBURY PHARMACEUTICALS's(P52:F) from its laster reported year is 0.00%

NEWBURY PHARMACEUTICALS's(P52:F) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...